Geftinat 250mg Tablet

Geftinat 250mg Tablet contains Gefitinib, a potent tyrosine kinase inhibitor that specifically targets the epidermal growth factor receptor (EGFR). This medication is widely used in the treatment of non-small cell lung cancer (NSCLC). By interfering with EGFR’s signaling pathways, Gefitinib disrupts cancer cell growth, making it a vital component in targeted cancer therapy.

Key Features:

• Contains Gefitinib, a proven targeted therapy agent
• Indicated for the treatment of non-small cell lung cancer (NSCLC)
• Effectively inhibits EGFR to slow down cancer cell proliferation
• Available in a convenient oral tablet form for ease of use
• Typically used as part of a broader cancer treatment plan